We have confirmed that the 28,000-molecular-weight (28K) protein encoded by the virA gene of the 90-kilobase Salmonella typhimurium virulence plasmid is a virulence factor. It was previously shown that a TnS insertion, vir-22::TnS, located in the virulence plasmid greatly attenuated virulence for mice and inhibited the production of a 28K protein (P. A. Gulig and R. Curtiss III, Infect. Immun. 56:3262-3271, 1988). Plasmid pYA426 fully complemented vir-22::TnS to virulence by increasing splenic infection after oral inoculation and encoded the 28K protein. To identify the virulence gene(s) of pYA426 mutated by vir-22::TnS, we constructed nested deletions in pYA426 and examined deletion derivatives for their abilities to complement vir-22::TnS. Only derivatives still producing the 28K protein complemented vir-22::TnS. Furthermore, the smallest complementing derivative encoded only the 28K protein, as determined by DNA sequence analysis. Therefore, the 28K protein is sufficient for complementation of the attenuating mutation vir-22::TnS and must be the virulence factor inhibited by the insertion. We determined the nucleotide sequence of the 1.2-kilobase BamHI-EcoRI fragment encoding the 28K protein and identified the structural gene, virA. A 723-base-pair open reading frame which encodes a peptide with a molecular weight of 27,572 was found.
The role of virulence plasmids in the pathogenesis of infection with several Salmonella species and serotypes has been the subject of considerable research during this decade (for a review, see reference 12a). A virulence plasmid is necessary for salmonellae to cause infection beyond the Peyer's patches of the intestines to the mesenteric lymph nodes and spleen after oral inoculation of mice (13, 26) . Although the contribution of the plasmid to virulence at the cellular or molecular levels has not been determined, the locations of several virulence genes and homologous regions of different plasmids have been identified. Deletion and transposon insertion mutagenesis (2, 3, 14, 23, 30) and cloning (14, 24) have been used to identify regions associated with virulence. Through restriction mapping of attenuating mutations and cloned virulence sequences, a common virulence region has been identified (2, 3, 12a, 14, 23, 24, 28, 30, 36) . Most recently, DNA sequence analysis has been reported for virulence plasmid genes (25, 32) .
Gulig and Curtiss (14) used cloning of the virulence plasmid into plasmid-cured Salmonella typhimurium to select for recombinant plasmids that encoded critical virulence genes. From virulence-conferring clones, a consensus virulence region of 14 kilobases (kb) was identified. This region coincided with virulence regions identified by others (12a) . A TnS insertion, vir-22::TnS, in the virulence region greatly attenuated virulence in mice in terms of splenic infection after oral inoculation and inhibited the production of a 28,000-molecular-weight (28K) protein. Plasmid pYA422 contained the 3.2-kb BamHI fragment corresponding to the site of insertion of vir-22::TnS, expressed only the 28K protein, and conferred virulence to plasmid-cured S. typhimurium in terms of 50% lethal dose. These results suggested * Corresponding author. that the 28K protein was an important plasmid-encoded virulence factor. Plasmid pYA426 contained the same 3.2-kb BamHI fragment, also produced the 28K protein, and fully complemented vir-22::TnS. However, the identity of the virulence gene(s) mutated by vir-22: :TnS was left in question because of the large size of the BamHI fragment and the possibility that vir-22::Tn5 exerted multigenic (i.e., polar) effects.
In this report, we demonstrate that the 28K protein alone is sufficient to complement vir-22: :TnS and therefore must be the virulence factor inhibited by this mutation. The DNA sequence of the gene virA encoding the 28K protein was determined. The nucleotide sequence data reported in this paper will appear in the EMBL, GenBank, and DDBJ nucleotide sequence data bases under the accession number M33927.
(A preliminary report of these data was presented at (20) . Antibiotics were used at the following concentrations (in micrograms per milliliter): ampicillin, 100; chloramphenicol, 30; kanamycin, 40; nalidixic acid, 50; and tetracycline, 25.
Genetic techniques. Transformation was performed as described by Humphreys et al. (17) . Plasmid extraction was done by the procedure of Bimboim (7) . Enzymes for manipulation of DNA were purchased from Bethesda Research Laboratories, Inc., Gaithersburg, Md., or Promega Corp., thr-1 ara-13 leu-6 azi-8 tonA2 lacYl minAl ginV44 Minicell producer (12) gal-6 minB2 rpsL135 xyl-7 mtl-2 thi-l
Madison, Wis., and used in accordance with manufacturer instructions. Deletion mutagenesis of pYA426. Unidirectional deletions were generated in pYA426 with exonuclease III (Bethesda Research Laboratories) exactly as described previously (16) . Briefly, pYA426 was linearized with SphI to generate a 3' cohesive end within the tetracycline resistance gene of pACYC184 and was then digested with XhoI to create a 5' cohesive end within the right end of the insert sequence (Fig.  1) . Exonuclease III was added to begin digestion into the 5' end of the XhoI site. At various times thereafter, the reaction was stopped, and the resulting single-stranded DNA was digested with Si nuclease and filled in with the Klenow fragment of DNA polymerase I. (14) were digested with BamHI, and the resulting fragments were subcloned into pUC19, selecting for kanamycin resistance. In this manner, the half of TnS containing the kanamycin resistance gene (5) (21, 27) .
Analysis of plasmid-encoded proteins with E. coli minicelis. Plasmid-encoded proteins were examined with E. coli minicells as described previously (14), with modifications as noted. Static overnight cultures of E. coli K-12 x925 containing the appropriate plasmid were grown in minicelllabeling medium (14) , which consisted of medium M9 (22) with all of the amino acids except methionine and containing thiamine hydrochloride. On the next day, these cultures were diluted 1:20 into 75 ml of prewarmed minicell-labeling medium and grown with shaking at 37°C to the late log phase (optical density at 600 nm, approximately 0.4). (14) . Furthermore, vir-26: :TnS and vir-27: :TnS, which do not affect the production of the 28K protein, mapped to the right of the EcoRI site (14) . These facts suggested that the 28K protein was encoded in the left sequences of pYA426, possibly within the BamHI-EcoRI fragment. To examine this possibility, we subcloned the fragment into pUC19 and pUC18, yielding pGTR001 and pGTR002, respectively (Fig. 1) Controls included wild-type X3306, plasmid-cured X3337, complementation of vir-22::TnS with pYA426, and lack of complementation by pACYC184. Plasmids pGTR124, pGTR125, and pGTR126, in which the deletions did not extend into the 1.2-kb BamHI-EcoRI fragment, fully complemented vir-22::Tn5. In contrast, plasmids pGTR120, pGTR121, and pGTR122, in which the deletions extended into the BamHI-EcoRI fragment, did not complement vir-22: :TnS. The BamHI-EcoRI subclone pGTR127 contained the shortest insert sequence capable of complementing vir-22::TnS. All of the plasmids which complemented vir-22::TnS produced the 28K protein, whereas the noncomplementing plasmids did not produce the 28K protein (Fig.  2 ). An exception was pGTR123, which consistently yielded intermediate complementation, although the deletion did not extend into the 1.2-kb BamHI-EcoRI fragment and the 28K protein was produced. The P value was less than 0.005 for splenic CFU of x3589 (pGTR123) when compared with both the positive and negative controls for complementation.
DNA sequence analysis of virA encoding the 28K protein. We determined the nucleotide sequence of the 1.2-kb BamHI-EcoRI fragment with pGTROO1, deletion derivatives, subclones, and synthetic oligonucleotide primers. Only a single complete open reading frame consisting of 723 base pairs was identified from nucleotides 393 to 1115 from the BamHI site (Fig. 3) . This open reading frame encodes a peptide with a deduced molecular weight of 27,572, in close agreement with the size of the 28K protein estimated from sodium dodecyl sulfate-polyacrylamide gel electrophoresis. On the basis of the correlation of the open reading frame with deletion analysis of pYA426 and expression of the 28K protein ( Fig. 2 and 3 (32) . Because virA was the only gene needed to complement vir-22::TnS, the 28K protein must be a virulence factor encoded by the S. typhimurium virulence plasmid.
A consensus ribosome-binding site (AGGAG) was identified 8 base pairs upstream of the ATG start codon, which was located at base pair 393 from the BamHI site (Fig. 3) (21, 27) , and no obviously homologous genes or peptides were identified. The deduced amino acid sequence was further examined with the Kyte-Doolittle algorithm for hydropathy (19) and the Chou-Fasman algorithm for secondary structure (9) . The 28K protein appears to be highly hydrophilic, with no stretches of hydrophobic sequences of more than five to six residues. No leaderlike sequence was apparent at the amino-terminal end. Therefore, the 28K protein is probably not an integral membrane protein, nor is it likely to be transported across the cytoplasmic membrane. The pI of the 28K protein was calculated to be 6.96 with the Isoelectric program of the Genetics Computer Group (11) .
DNA sequence analysis of previously described TnS insertions. As part of the initial characterization of the S. typhimurium SR-11 virulence plasmid, four TnS insertions (vir-l::TnS, vir-3::TnS, vir4::TnS, and vir-7::Tn5) were iso- lated in the 3.2-kb BamHI insert sequence of pYA422 (14) .
inhibited the production of the 28K protein, was located at
We therefore used DNA sequence analysis to identify the base 552 of the 1. (14) . DISCUSSION Molecular analysis of the genetics of plasmid-mediated virulence of S. typhimurium by Gulig and Curtiss (14) identified a TnS insertion, vir-22::TnS, which greatly attenuated virulence and inhibited the production of the 28K protein. However, pYA422, which expressed the 28K protein, did not complement vir-22::TnS for splenic infection. When the insert sequence of pYA422 (a 3.2-kb BamHI fragment) was inverted in the vector pACYC184, the resulting plasmid, pYA426, encoded the 28K protein and was able to complement vir-22::TnS for splenic infection. This situation left some confusion as to the exact role of the 28K protein in the virulence of S. typhimurium. In the present study, we demonstrate that the 28K protein encoded by virA of pYA426 is necessary and sufficient to complement vir-22: :TnS. Therefore, the 28K protein is the virulence factor directly inhibited by vir-22::TnS and must be a determinant for the plasmid-encoded pathogenicity of S. typhimurium.
An anomalous result obtained by complementation analysis of vir-22::TnS with deletion derivatives of pYA426 was that plasmid pGTR123 incompletely complemented vir-22::TnS, although the flanking deletion derivatives pGTR127 and pGTR124 completely complemented the TnS insertion (Table 2 and The deduced amino acid sequence of the 28K protein is highly hydrophilic, suggesting a cytoplasmic location for the protein. Such a location suggests a regulatory role for the 28K protein. vir-22::Tn5 results in the lack of expression of the production of the 28K protein, but not the 29K and 32K proteins, expressed by E. coli minicells possessing cosmid clones that confer full virulence to plasmid-cured S. typhimurium (14) . If the 28K protein were either a repressor or an inducer of other identified virulence plasmid genes, then quantitative or qualitative differences in the production of other proteins would be expected to result from the vir-22: :TnS mutation. However, a role for the 28K protein in the expression of chromosomally encoded genes has not been examined, and the expression of other plasmid-encoded genes possibly affected by virA may be dependent on chromosomal genes of S. typhimurium not present in E. coli. (6) . Further work needs to be done to elucidate the roles of the location and orientation of vir-7::TnS and vir-22::TnS in the expression of virA. Definitive identification of the promoter for virA awaits analysis of mRNA structure.
In addition to having its own promoter, virA may be part of the transcript of the mkaA gene identified and sequenced by Taira and Rhen (32) , which is upstream and colinear with virA, ending at base 108. This hypothesis could explain why pYA422 does not complement vir-22::TnS, although pYA422 fully encodes virA and a functional promoter. pYA422 lacks readthrough transcription possibly provided from mkaA or an upstream promoter such as the tetracycline resistance gene of pYA426 and may not sufficiently express virA for complementation. In contrast, virA of pYA426 could derive additional transcription from the tetracycline resistance gene of pACYC184. Consistent with this hypothesis, we have measured at least fivefold-higher levels of transcription of virA in pYA426 than in pYA422 (P. A. Gulig, unpublished data).
Others have used molecular genetic analysis to examine potential virulence genes of the S. typhimurium plasmid. Hackett et al. (15) have cloned a gene which confers increased serum resistance to E. coli K-12, and VandenBosch et al. (33) (34) (35) have identified, cloned, and sequenced a locus named rsk which is involved in the regulation of chromosomally encoded virulence factors. However, the direct role of these two loci in plasmid-mediated virulence has not been investigated through mutational-complementational analysis. Norel et al. (24) have also cloned regions of the virulence plasmid and have identified protein products from sequences which encode virulence functions. virA falls within the center of all consensus virulence regions identified by Gulig and Curtiss (14) and others (2, 3, 12a, 23, 24, 28, 30, 36 
